Home › Stocks › PRAX › All Fund Holders
PRAX — PRAXIS PRECISION MEDICINES I · All Fund Holders
Funds holding (latest): 44 · Reported value held: $4.15B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 2.32M | $775.68M | 0.04% | Add |
| BlackRock Inc history | Q2 2026 | 2.29M | $767.53M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 1.46M | $430.60M | 0.01% | Add |
| Point72 Asset Management history | Q4 2025 | 992.35K | $292.48M | 0.34% | Reduce |
| Morgan Stanley history | Q2 2026 | 854.11K | $285.95M | 0.02% | Add |
| Geode Capital Management history | Q2 2026 | 748.04K | $250.48M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 548.83K | $183.74M | 0.02% | Reduce |
| Bank of America Corp history | Q2 2026 | 546.93K | $183.11M | 0.01% | Add |
| Invesco Ltd history | Q2 2026 | 537.55K | $179.97M | 0.01% | Add |
| Norges Bank Investment Management history | Q2 2026 | 346.97K | $116.16M | 0.01% | Add |
| Franklin Resources history | Q2 2026 | 327.12K | $109.52M | 0.03% | Add |
| Northern Trust Corp history | Q2 2026 | 240.89K | $80.65M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 220.01K | $73.66M | 0.01% | Add |
| Marshall Wace history | Q2 2026 | 137.01K | $45.87M | 0.04% | Add |
| UBS Group AG history | Q2 2026 | 131.05K | $43.87M | 0.01% | Add |
| Wellington Management Group history | Q2 2026 | 125.87K | $42.14M | 0.01% | Reduce |
| MFS Investment Management history | Q2 2026 | 107.41K | $35.96M | 0.01% | Add |
| Capital Research Global Investors history | Q1 2025 | 853.75K | $32.33M | 0.01% | Reduce |
| BNY Mellon history | Q2 2026 | 85.38K | $28.58M | 0.01% | Reduce |
| Janus Henderson Group history | Q1 2026 | 84.95K | $27.36M | 0.01% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 64.26K | $21.51M | 0.01% | Add |
| AQR Capital Management history | Q2 2026 | 58.45K | $19.57M | 0.01% | Hold |
| Renaissance Technologies history | Q4 2025 | 66.23K | $19.52M | 0.03% | New |
| Citadel Advisors history | Q2 2026 | 50.33K | $16.85M | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 44.09K | $15.81M | 0.00% | New |
| CPP Investments history | Q1 2026 | 40.13K | $12.93M | 0.01% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 27.89K | $9.34M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 26.15K | $8.75M | 0.01% | Reduce |
| Citigroup Inc history | Q2 2026 | 23.60K | $7.90M | 0.00% | Add |
| Prudential Financial history | Q2 2026 | 19.54K | $6.54M | 0.01% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 19.03K | $6.37M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 18.76K | $6.28M | 0.01% | Add |
| D. E. Shaw & Co history | Q2 2026 | 10.14K | $3.39M | 0.00% | Add |
| Farallon Capital Management history | Q1 2024 | 50.00K | $3.05M | 0.01% | New |
| Polen Capital Management history | Q2 2026 | 7.25K | $2.43M | 0.02% | Reduce |
| Royce & Associates history | Q2 2026 | 6.54K | $2.19M | 0.02% | New |
| PSP Investments history | Q4 2025 | 3.30K | $971.76K | 0.00% | New |
| Principal Global Investors history | Q2 2026 | 1.92K | $643.47K | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 1.88K | $629.40K | 0.00% | New |
| Amundi US history | Q2 2026 | 1.72K | $574.16K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 1.59K | $533.32K | 0.00% | Add |
| Millennium Management history | Q2 2026 | 995 | $333.12K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 943.00K | $315.71K | 0.03% | Add |
| Harvard Management Company history | Q2 2023 | 692.62K | $797 | 0.08% | Reduce |